Matches in Wikidata for { <http://www.wikidata.org/entity/Q86298305> ?p ?o ?g. }
Showing items 1 to 30 of
30
with 100 items per page.
- Q86298305 description "clinical trial" @default.
- Q86298305 description "ensayu clínicu" @default.
- Q86298305 description "klinisch onderzoek" @default.
- Q86298305 description "клінічне випробування" @default.
- Q86298305 description "կլինիկական փորձարկում" @default.
- Q86298305 name "Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors" @default.
- Q86298305 name "Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors" @default.
- Q86298305 type Item @default.
- Q86298305 label "Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors" @default.
- Q86298305 label "Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors" @default.
- Q86298305 prefLabel "Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors" @default.
- Q86298305 prefLabel "Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors" @default.
- Q86298305 P1132 Q86298305-C4AE031B-8F3E-4AE1-9C61-2979D78851EF @default.
- Q86298305 P1476 Q86298305-CA5EA219-9ECB-4628-AB4A-AECC48E8CA31 @default.
- Q86298305 P2899 Q86298305-C6DB70FF-D6E2-4EC5-A585-752B4B98B0E6 @default.
- Q86298305 P3098 Q86298305-3FDF3D4B-F2AA-4002-AA90-C38018DC40CE @default.
- Q86298305 P31 Q86298305-E5E9DA45-821E-48B0-8B15-204C218195D6 @default.
- Q86298305 P580 Q86298305-FD7145B9-8530-4D30-AB4F-0E00E4A9965E @default.
- Q86298305 P582 Q86298305-583D2B27-886F-4D44-92F8-8839E868DF16 @default.
- Q86298305 P6099 Q86298305-0D2046AB-1867-4929-ABC9-46FDBCD831E0 @default.
- Q86298305 P8363 Q86298305-6BA0EA37-B430-483B-A957-1D1A0C0A3E2B @default.
- Q86298305 P1132 "+69" @default.
- Q86298305 P1476 "A First-in-Human, Phase 1a/1b, Open Label, Dose-Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, and Antitumor Activity of the RAF Dimer Inhibitor BGB-3245 in Patients With Advanced or Refractory Tumors" @default.
- Q86298305 P2899 "+18" @default.
- Q86298305 P3098 "NCT04249843" @default.
- Q86298305 P31 Q30612 @default.
- Q86298305 P580 "2020-01-24T00:00:00Z" @default.
- Q86298305 P582 "2023-05-01T00:00:00Z" @default.
- Q86298305 P6099 Q5452194 @default.
- Q86298305 P8363 Q78089383 @default.